Dongsung Pharm Working Capital to Net Assets Ratio
Dongsung Pharm working capital to net assets ratio. Dongsung Pharm (002210) has a Working Capital to Net Assets ratio of -72.6% as of June 2025. Working capital of ₩-29.45 Billion (current assets of ₩60.12 Billion minus current liabilities of ₩89.57 Billion) is measured against net assets of ₩40.55 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Dongsung Pharm (002210) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Dongsung Pharm (2008–2024)
Working capital to net assets ratio of Dongsung Pharm from 2008 to 2024. This chart shows how Dongsung Pharm's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2008 to 2024. As of June 2025, the ratio stands at -72.6%, reflecting working capital of ₩-29.45 Billion against net assets of ₩40.55 Billion KRW. See Dongsung Pharm (002210) defensive interval to measure how many days the company can operate on defensive assets alone.
Dongsung Pharm Working Capital to Net Assets Ratio by Year (2008–2024)
Dongsung Pharm working capital to net assets ratio by year from 2008 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Dongsung Pharm from 2008 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see 002210 total assets.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -16.1% | ₩-8.88 Billion | ₩55.18 Billion | ₩68.15 Billion | ₩77.03 Billion | ▼ -56.2 pp |
| 2023 | 40.1% | ₩15.97 Billion | ₩39.80 Billion | ₩60.81 Billion | ₩44.84 Billion | ▲ +24.2 pp |
| 2022 | 15.9% | ₩6.82 Billion | ₩42.81 Billion | ₩54.39 Billion | ₩47.57 Billion | ▼ -10.8 pp |
| 2021 | 26.7% | ₩12.40 Billion | ₩46.44 Billion | ₩49.99 Billion | ₩37.59 Billion | ▼ -16.4 pp |
| 2020 | 43.1% | ₩23.67 Billion | ₩54.95 Billion | ₩71.51 Billion | ₩47.83 Billion | ▼ -12.3 pp |
| 2019 | 55.4% | ₩38.85 Billion | ₩70.10 Billion | ₩79.40 Billion | ₩40.55 Billion | ▼ -15.3 pp |
| 2018 | 70.7% | ₩40.65 Billion | ₩57.48 Billion | ₩87.79 Billion | ₩47.14 Billion | ▲ +11.8 pp |
| 2017 | 58.9% | ₩37.84 Billion | ₩64.27 Billion | ₩74.52 Billion | ₩36.68 Billion | ▼ -10.6 pp |
| 2016 | 69.4% | ₩38.62 Billion | ₩55.62 Billion | ₩77.08 Billion | ₩38.46 Billion | ▲ +29.4 pp |
| 2011 | 40.1% | ₩24.13 Billion | ₩60.20 Billion | ₩75.05 Billion | ₩50.92 Billion | ▼ -0.5 pp |
| 2010 | 40.5% | ₩23.96 Billion | ₩59.10 Billion | ₩76.95 Billion | ₩52.99 Billion | ▼ -7.2 pp |
| 2009 | 47.8% | ₩32.46 Billion | ₩67.97 Billion | ₩76.21 Billion | ₩43.75 Billion | ▼ -6.2 pp |
| 2008 | 54.0% | ₩36.60 Billion | ₩67.82 Billion | ₩72.62 Billion | ₩36.02 Billion | — |